Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]
News [7844]
Articles [63]
Editorials [9]
Conferences [211]
elearning [49]
Nivolumab in combination with CIMAvax-EGF for lung cancer
Dr Grace Dy - Roswell Park Cancer Institute, USA
Nivolumab in combination with CIMAvax-EGF for lung cancer ( Dr Grace Dy - Roswell Park Cancer Institute, USA )
4 Jan 2019
Bispecific CD19/22 CAR therapy in children and young adults with ALL
Dr Liora M Schultz - Stanford University, Palo Alto, USA
Bispecific CD19/22 CAR therapy in children and young adults with ALL ( Dr Liora M Schultz - Stanford University, Palo Alto, USA )
17 Dec 2018
Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone...
Dr Mark Bustoros - Harvard Medical School, Boston, USA
Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone in high-risk smouldering multiple myeloma ( Dr Mark Bustoros - Harvard Medical School, Boston, USA )
17 Dec 2018
Phase II trial of nivolumab combined with ibrutinib for patients with Richter...
Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA
Phase II trial of nivolumab combined with ibrutinib for patients with Richter transformation ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )
17 Dec 2018
Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia
Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona...
Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia ( Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona, Spain )
17 Dec 2018
Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed...
Dr Habte Yimer - Texas Oncology, Tyler, USA
Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed multiple myeloma ( Dr Habte Yimer - Texas Oncology, Tyler, USA )
17 Dec 2018
Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from...
Dr Dejan Juric - Massachusetts General Hospital, Boston, USA
Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial ( Dr Dejan Juric - Massachusetts General Hospital, Boston, USA )
14 Dec 2018
Modulation of anti-tumour immunity using CDK4/6 inhibitors
Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA
Modulation of anti-tumour immunity using CDK4/6 inhibitors ( Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2018
Brain metastases developed from HER2 positive and triple negative breast cancer
Dr Patricia Steeg - National Cancer Institute, Bethesda, USA
Brain metastases developed from HER2 positive and triple negative breast cancer ( Dr Patricia Steeg - National Cancer Institute, Bethesda, USA )
14 Dec 2018
SABCS 2018: Highlights in breast cancer treatment
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
SABCS 2018: Highlights in breast cancer treatment ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
13 Dec 2018
Low-dose tamoxifen as effective as higher doses for breast cancer patients
Prof Andrea De Censi - S.C. Oncologia Medica, Genoa, Italy
Low-dose tamoxifen as effective as higher doses for breast cancer patients ( Prof Andrea De Censi - S.C. Oncologia Medica, Genoa, Italy )
13 Dec 2018
Improved IDFS for breast cancer patients who received trastuzumab emtansine
Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA
Improved IDFS for breast cancer patients who received trastuzumab emtansine ( Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA )
13 Dec 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation